Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-04

Clinical Trial Update: Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Recurrent Mouth or Throat Dysplasia or Recurrent In Situ Cancer or Stage I Cancer of the Mouth or Throat [NA]

View source ↗

Summary

This ClinicalTrials.gov entry reports termination of a study evaluating photodynamic therapy with porfimer sodium for recurrent mouth or throat dysplasia or sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Photofrin (porfimer sodium)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Head and Neck Cancer | NA | Status: TERMINATED | Results posted: 2014-07-04